Aoyama, Y., Nishimura, T., Sawamoto, T., Satoh, T., Katashima, M., & Nakagawa, K. (2012). Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: Dose proportionality and influence of renal impairment. Springer-Verlag.
Chicago Style CitationAoyama, Yumiko, Tetsuya Nishimura, Taiji Sawamoto, Taroh Satoh, Masataka Katashima, i Kazuhiko Nakagawa. Pharmacokinetics of Sepantronium Bromide (YM155), a Small-molecule Suppressor of Survivin, in Japanese Patients With Advanced Solid Tumors: Dose Proportionality and Influence of Renal Impairment. Springer-Verlag, 2012.
Cita MLAAoyama, Yumiko, et al. Pharmacokinetics of Sepantronium Bromide (YM155), a Small-molecule Suppressor of Survivin, in Japanese Patients With Advanced Solid Tumors: Dose Proportionality and Influence of Renal Impairment. Springer-Verlag, 2012.